Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Influenza

Free Subscription 06.08.2018 2 Arch Virol 1 Biochem Biophys Res Commun 2 J Infect Dis 4 Lancet Infect Dis 2 PLoS One 1 Proc Natl Acad Sci U S A 4 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Arch Virol

1. AL KHATIB HA, Al Thani AA, Yassine HM
   Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.
   Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3962.
   PubMed     Text format     Abstract available
   
   
2. JANG Y, Jin M, Seo SH
   Histamine contributes to severe pneumonia in pigs infected with 2009 pandemic H1N1 influenza virus.
   Arch Virol. 2018 Jul 31. pii: 10.1007/s00705-018-3973.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

3. WANG J, Liu M, Ding N, Li Y, et al
   Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice.
   Biochem Biophys Res Commun. 2018 Jul 28. pii: S0006-291X(18)31633.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

4. TREANOR J
   Influenza Challenge and the Challenge of Drug Development.
   J Infect Dis. 2018 Jul 26. pii: 5060130. doi: 10.1093.
   PubMed     Text format    
   
   
5. YOGARATNAM J, Rito J, Kakuda TN, Fennema H, et al
   Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study.
   J Infect Dis. 2018 Jul 26. pii: 5060129. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Infect Dis

6. SHANKS GD, Wilson N, Kippen R, Brundage JF, et al
   Host and viral genetic diversity can help explain mortality during the 1918-21 influenza pandemic in the Pacific region - Authors' reply.
   Lancet Infect Dis. 2018;18:834.
   PubMed     Text format    
   
   
7. ATWELL JE, Karron RA
   Vaccination against respiratory syncytial virus in pregnancy.
   Lancet Infect Dis. 2016;16:1330-1331.
   PubMed     Text format    
   
   
8. HANON E, Van der Most R, Del Giudice G, Rappuoli R, et al
   Short-term and mid-term solutions for influenza vaccines.
   Lancet Infect Dis. 2018;18:832-833.
   PubMed     Text format    
   
   
9. TARANTOLA A, Horwood P, Richard V, Quintana-Murci L, et al
   Host and viral genetic diversity can help explain mortality during the 1918-21 influenza pandemic in the Pacific region.
   Lancet Infect Dis. 2018;18:833-834.
   PubMed     Text format    
   
   

   
   PLoS One

10. AGUSTININGSIH A, Trimarsanto H, Restuadi R, Artika IM, et al
    Evolutionary study and phylodynamic pattern of human influenza A/H3N2 virus in Indonesia from 2008 to 2010.
    PLoS One. 2018;13:e0201427.
    PubMed     Text format     Abstract available
    
    
11. MACHABLISHVILI A, Chakhunashvili G, Zakhashvili K, Karseladze I, et al
    Overview of three influenza seasons in Georgia, 2014-2017.
    PLoS One. 2018;13:e0201207.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

13. NOH JY, Choi WS, Song JY, Lee HS, et al
    Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
    PubMed     Text format     Abstract available
    
    
14. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
    Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
    Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
    PubMed     Text format     Abstract available
    
    
15. ALBRIGHT K, Hurley LP, Lockhart S, Gurfinkel D, et al
    Attitudes about adult vaccines and reminder/recall in a safety net population.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31543.
    PubMed     Text format     Abstract available
    
    
16. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
    Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: